Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro

References

• Prausnitz MR, Mitragotri S, Langer R. 2004. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3:115–124.
   PubMed Web of Science ®Google Scholar
• Hadgraft J, Lane M. 2006. Passive transdermal drug delivery systems: recent considerations and advances. Am J Drug Deliv 4:153–160.
   Google Scholar
• Benson HAE. 2005. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2:23–33.
   PubMedGoogle Scholar
• Zhao LG, Fang L, Xu YN, Liu S, He ZG, Zhao YY. 2008. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers. Eur J Pharm Biopharm 69:199–213.
   PubMed Web of Science ®Google Scholar
• Zhao LG, Fang L, Xu YN, Zhao YY, He ZG. 2008. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity. Int J Pharm 352:92–103.
   PubMed Web of Science ®Google Scholar
• Zhang WL, Li RH. 2007. Advanced review of daphnetin pharmacological effect. Shi yong zhong yi zha zhi 23:402–403.
   PubMedGoogle Scholar
• Gao Q, Shan J, Di L, Jiang L, Xu H. 2008. Therapeutic effects of daphnetin on adjuvant-induced arthritic rats. J Ethnopharmacol 120:259–63.
   PubMed Web of Science ®Google Scholar
• Li SH, Wu LJ, Yin HY. 2002. Chemical and pharmacological advances of the study on zushima. Zhongguo Zhong Yao Za Zhi 27:401–403.
   PubMedGoogle Scholar
• Li CL, Ye YW, Liang ZF. 1983. Comparison of dapne extrat before and after removal of poison constituent. Zhong guo yi yuan yao xue za zhi 3:318–319.
   Google Scholar
• Sales OD, Castellano AL, Lacer FJM, Dominguez MH. 1993. An in vitro percutaneous absorption study of non-ionic compound s across human skin. Pharmazie 48:684–686.
   PubMed Web of Science ®Google Scholar
• Fang L, Kobayashi Y, Numajiri S, Kobayashi D, Sugibayashi K, Morimoto Y. 2002. The enhancing effect of a triethanolamine–ethanol–isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol Pharm Bull 25:1339–1344.
   PubMed Web of Science ®Google Scholar
• Niazy EM. 1996. Differences in penetration-enhancing effect of Azone throughexcised rabbit, rat, hairless mouse, guinea pig and human skins. Int J Pharm 130:225–230.
   Web of Science ®Google Scholar
• Fedors RF. 1974. A method for estimating both the solubility parameters and molar volumes of liquids. Polym Eng Sci 14:147–154.
   Web of Science ®Google Scholar
• Scheuplein RJ. 1978. Site variations in diffusion and permeability. In: Jarret A, ed. The Physiology and Pathophysiology of Skin. New York: Academic Press, 1693–1730.
   Google Scholar
• Williams AC, Barry BW. 1991. Terpenes and the lipid-protein partitioning theory of skin penetration enhancement. Pharm Res 8:17–24.
   PubMed Web of Science ®Google Scholar
• Ullah N, Ahmed S, Muhammad P, Ahmed Z, Nawaz HR, Malik A. 1999. Coumarinolignoid glycoside from Daphne oleoides. Phytochemistry 51:103–105.
   Web of Science ®Google Scholar
• Kraeling MEK, Bronaugh RL. 1997. In vitro percutaneous absorption of alpha hydroxyl acids in human skin. J Soc Cosmet Chem 48:187–197.
   Web of Science ®Google Scholar
• Narishetty ST, Panchagnula R. 2004. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Contr Rel 95:367–379.
   PubMed Web of Science ®Google Scholar
• Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK. 1995. Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci 84:312–317.
   PubMed Web of Science ®Google Scholar
• Yoneto K, Li SK, Higuchi WI, Shimabayashi S. 1997. Influence of the permeation enhancers 1-alkyl-2-pyrrolidones on permeant partitioning into the stratum corneum. J Pharm Sci 87:209–214.
   Web of Science ®Google Scholar
• Koizumi A, Fujii M, Kondoh M, Watanabe Y. 2004. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm 57:473–478.
   PubMed Web of Science ®Google Scholar
• Williams AC, Megrab NA, Barry BW. 1995. Permeation of oestradiol through human epidermal and silastic membranes from saturated transcutol/water systems. In: Brain KR, Walters KA, James VJ, eds. Prediction of percutaneous penetration. Cardiff: STS Publishing, pp. 43.
   Google Scholar
• Ritscel WA, Panchagnula R, Stemmer K, Ashraf M. 1991. Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanisms of depot. Skin Pharmacol. 4:235–245.
   PubMedGoogle Scholar
• Williams AC, Barry BW. 2004. Penetration enhancers. Adv Drug Deliv Rev 56:603–618.
   PubMed Web of Science ®Google Scholar
• Harrison JE, Watkinson AC, Green DM, Hadgraft J, Brain K. 1996. The relative effect of Azone and Transcutol on permeant diffusivity and solubility in human stratum corneum. Pharm Res 13:542–546.
   PubMed Web of Science ®Google Scholar
• Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. 2001. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52:103–112.
   PubMed Web of Science ®Google Scholar
• Lewis D, Hadgraft J. 1990. Mixed monolayers of dipalmitoylphospatidylcholine with Azonew or oleic acid at the air–water interface. Int J Pharm 65:211–218.
   Web of Science ®Google Scholar
• Brown MB, Hanpanitcharoen M, Martin GP. 2001. An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. Int J Pharm 225:113–121.
   PubMed Web of Science ®Google Scholar
• Garcia MT, da Silva CH, de Oliveira DC, Braga EC, Thomazini JA, Bentley MV. 2006. Transdermal delivery of ketoprofen: the influence of drug-dioleylphosphatidylcholine interactions. Pharm Res 23:1776–1785.
   PubMed Web of Science ®Google Scholar
• Copoví A, Díez-Sales O, Herráez-Domínguez JV, Herráez-Domínguez M. 2006. Enhancing effect of alpha-hydroxyacids on ‘in vitro’ permeation across the human skin of compounds with different lipophilicity. Int J Pharm 314:31–36.
   PubMedGoogle Scholar